Evotec, Novo Nordisk Roll Out LAB EN To Accelerate Translation In Cardiometabolic Diseases
(RTTNews) - Evotec SE (EVO, EVOTF.PK) and Novo Nordisk A/S (NVO) announced Tuesday a translational drug discovery accelerator called LAB eN, which aims to nurture early research from academic institutions into novel therapeutics.
LAB eN is a unique engagement model that combines Evotec's multimodality drug discovery and pre-clinical development capabilities with Novo Nordisk's therapeutic, clinical, and commercial expertise.
LAB eN will focus on addressing unmet need in cardiometabolic diseases as well as rare blood and rare endocrine disorders.
LAB eN has already signed on four academic institutions to participate: Harvard University, Mass General Brigham, Yale University, and Beth Israel Deaconess Medical Center.
baca selengkapnya
Novo Nordisk Stock Climbs On Higher Q1 Results; Cuts FY25 Outlook
Shares of Novo Nordisk A/S were gaining around 6 percent in Denmark as well as around 7 percent in the pre-market activity on the NYSE, after the Danish drug major reported Wednesday higher profit and sales in its first quarter, mainly reflecting improved results of its blockbuster weight loss drug Wegovy. Meanwhile, the company trimmed fiscal 2025 outlook for sales and operating profit growth...
RTTNews
|
506 hari yang lalu
Novo Nordisk Plans $4.1 Bln NC Facility To Boost Obesity Drug Supply
Danish drug maker Novo Nordisk announced its plans to invest $4.1 billion or about 27 billion Danish kroner to build a new manufacturing plant in Clayton, North Carolina with a view to expanding its manufacturing capacity in the United States. In the new plant, the company plans to produce current and future injectable treatments for people with obesity and other serious chronic diseases.
RTTNews
|
822 hari yang lalu
Novo Nordisk Says FLOW Trial Achieves Primary Endpoint
Novo Nordisk A/S (NVO) announced Tuesday the headline results from the kidney outcomes trial FLOW. The announcement follows the decision to stop the trial early due to efficacy.
RTTNews
|
934 hari yang lalu
Novo Nordisk Slashes US List Prices Of Several Insulin Products By Up To 75%
Healthcare company Novo Nordisk Inc. (NVO) announced Tuesday it is lowering the U.S. list prices of several pre-filled insulin pens and vials by up to 75% for people living with type 1 and type 2 diabetes.
RTTNews
|
1291 hari yang lalu
Swiss Market Ends Modestly Higher
The Switzerland market ended modestly higher on Friday, after moving in a narrow range in positive territory right through the session. Lower oil prices and bond yields amid hopes about potential opening of the Strait of Hormuz in seven days lifted investor sentiment.
RTTNews
|
1 jam 8 menit yang lalu
European Stocks Rise On Oil Decline, Middle East Peace Hopes
European stocks rose Friday following a more than 2% decline in Brent crude futures and falling bond yields, supported by reports that Iran has submitted a proposal to end Middle East hostilities. Major indices including the DAX and FTSE 100 posted modest gains.
RTTNews
|
1 jam 36 menit yang lalu
U.S. Consumer Sentiment Drops Less Than Previously Estimated In September
Revised data released by the University of Michigan on Friday showed consumer sentiment in the U.S. deteriorated by less than previously estimated in the month of September. The University of Michigan said its consumer sentiment index for September was upwardly revised to 48.1 from a preliminary reading of 47.8.
RTTNews
|
5 jam 41 menit yang lalu
Bay Street Poised For Positive Open On Metal Gains
Higher gold and silver futures support Canadian stock sentiment Friday morning. Iranian officials have submitted peace proposals to U.S. mediators this week. BlackBerry's adjusted net income rose 79% to $43.2 mln in the second quarter.
RTTNews
|
7 jam 20 menit yang lalu
